Gemcitabine-resistant pancreatic ductal adenocarcinoma cells promote immunosuppressive tumor microenvironment

被引：0
|
作者：
Kajiwara, Yoshinori [1 ,2 ]
Tazawa, Hiroshi
Nishiyama, Takeyoshi [1 ]
Shoji, Ryohei [1 ]
Fushimi, Takuro [1 ]
Kikuchi, Satoru [3 ]
Kuroda, Shinji
Noma, Kazuhiro
Yoshida, Ryuichi [1 ]
Nishizaki, Masahiko
Kagawa, Shunsuke
Fujiwara, Toshiyoshi
机构：
[1] Okayama Univ, Grad Sch Med, Dept Surg Gastroenterol, Okayama, Japan
[2] Okayama Univ Hosp, Ctr Inno Clin Med, Okayama, Japan
[3] Okayama Univ, Grad Sch Med Dent & Pharm Sci, Okayama, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OJ17-2-6
引用
收藏
页码：560 / 560
页数：1
相关论文
共 50 条
  • [1] Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma
    Nishi, Hidemi
    Gotoh, Kunihito
    Tomimaru, Yoshito
    Kobayashi, Shogo
    Sasaki, Kazuki
    Iwagami, Yoshifumi
    Yamada, Daisaku
    Akita, Hirofumi
    Asaoka, Tadafumi
    Noda, Takehiro
    Takahashi, Hidenori
    Tanemura, Masahiro
    Doki, Yuichiro
    Eguchi, Hidetoshi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2023, 92 (04) : 303 - 314
  • [2] Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma
    Hidemi Nishi
    Kunihito Gotoh
    Yoshito Tomimaru
    Shogo Kobayashi
    Kazuki Sasaki
    Yoshifumi Iwagami
    Daisaku Yamada
    Hirofumi Akita
    Tadafumi Asaoka
    Takehiro Noda
    Hidenori Takahashi
    Masahiro Tanemura
    Yuichiro Doki
    Hidetoshi Eguchi
    [J]. Cancer Chemotherapy and Pharmacology, 2023, 92 : 303 - 314
  • [3] Identification of a Novel Subpopulation of Tumor-Initiating Cells from Gemcitabine-Resistant Pancreatic Ductal Adenocarcinoma Patients
    Shimizu, Kazuya
    Chiba, Sachie
    Hori, Yuichi
    [J]. PLOS ONE, 2013, 8 (11):
  • [4] Mast Cells Promote Fibrotic Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
    Ma, Y.
    Hwang, R.
    Logsdon, C.
    Ullrich, S. E.
    [J]. PANCREAS, 2011, 40 (08) : 1336 - 1336
  • [5] Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells
    Ami N. Shah
    Justin M. Summy
    Jing Zhang
    Serk In Park
    Nila U. Parikh
    Gary E. Gallick
    [J]. Annals of Surgical Oncology, 2007, 14 : 3629 - 3637
  • [6] Development and characterization of gemcitabine-resistant pancreatic tumor cells
    Shah, Ami N.
    Summy, Justin M.
    Zhang, Jing
    Park, Serk In
    Parikh, Nila U.
    Gallick, Gary E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (12) : 3629 - 3637
  • [7] Gemcitabine enhances the transport of nanovector-albumin-bound paclitaxel in gemcitabine-resistant pancreatic ductal adenocarcinoma
    Borsoi, Carlotta
    Leonard, Fransisca
    Lee, Yeonju
    Zaid, Mohamed
    Elganainy, Dalia
    Alexander, Jenolyn Francisca
    Kai, Megumi
    Liu, Yan Ting
    Kang, Yaan
    Liu, Xuewu
    Koay, Eugene J.
    Ferrari, Mauro
    Godin, Biana
    Yokoi, Kenji
    [J]. CANCER LETTERS, 2017, 403 : 296 - 304
  • [8] Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma
    Shea, Jill E.
    Nam, Kweon-Ho
    Rapoport, Natalya
    Scaife, Courtney L.
    [J]. HPB, 2011, 13 (03) : 153 - 157
  • [9] Combination effect of metformin with gemcitabine for gemcitabine-resistant pancreatic adenocarcinoma
    Suzuki, Keiichi
    Takeuchi, Osamu
    Osaku, Masayoshi
    Yamada, Yoshinori
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [10] Development of gemcitabine-resistant patient-derived xenograft models of pancreatic ductal adenocarcinoma
    Miller, Aubrey L.
    Garcia, Patrick L.
    Gamblin, Tracy L.
    Vance, Rebecca B.
    Yoon, Karina J.
    [J]. CANCER DRUG RESISTANCE, 2020, 3 (03) : 572 - 585
12345